Kamiren Xl (Doxazosin)

Doxazosin is an alpha‑1 blocker indicated for conditions that involve elevated vascular tone or prostatic smooth‑muscle contraction.

• Hypertension: lowers systolic and diastolic blood pressure by reducing peripheral vascular resistance.
• Benign prostatic hyperplasia: improves urinary flow and relieves storage symptoms by relaxing prostatic smooth muscle.
• Renal hypertension (e.g., due to renal artery stenosis): assists blood‑pressure control when renal vascular resistance contributes to elevated pressure.

• Doxazosin selectively blocks alpha‑1 adrenergic receptors on vascular smooth muscle and prostatic stromal tissue. This inhibition prevents norepinephrine‑mediated vasoconstriction, producing arterial dilation and reduced peripheral resistance, while also relaxing prostatic smooth muscle to ease urinary obstruction.

Doxazosin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Dizziness or light‑headedness
• Headache
• Fatigue or weakness
• Nasal congestion
• Peripheral edema
• Nausea or abdominal discomfort

Serious or Rare Side Effects

• Severe hypotension or syncope
• Tachycardia or arrhythmia
• Significant liver enzyme elevation
• Anaphylactic or severe allergic reaction
• Priapism or prolonged erection
• Acute renal failure in susceptible individuals

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

• Blood pressure monitoring: check orthostatic readings after the first dose and during titration.
• Cardiovascular assessment: use caution in patients with existing heart failure or recent myocardial infarction.
• Renal and hepatic function: adjust therapy if severe impairment is present.
• Concomitant antihypertensives: avoid excessive hypotension by reviewing all blood‑pressure‑lowering agents.
• Discontinuation: taper gradually rather than stopping abruptly to prevent rebound hypertension.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Doxazosin can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Other alpha‑1 blockers (e.g., terazosin, prazosin): additive vasodilatory effect leading to profound hypotension.
• Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase plasma concentrations and risk of adverse events.
• Concurrent use with other antihypertensives (e.g., ACE inhibitors, diuretics) without dose adjustment: may cause severe blood‑pressure drops.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance orthostatic hypotension; monitor electrolytes and volume status.

• NSAIDs: can blunt antihypertensive response; assess blood‑pressure control.
• Beta‑blockers: combined effect on heart rate and blood pressure; observe for bradycardia.
• Sildenafil or other PDE‑5 inhibitors: risk of additive hypotension; advise caution.